Globally, substandard or falsified medicines impact millions of lives every year, including hundreds of thousands of deaths in under developed countries such as African countries. In addition, medicinal products quality violations add to significant administrative burden on governments and concerned health agencies along with the manufacturers.
Artixio, for one of its clients, has developed an Artificial Intelligence based web application to centralize, harmonize and share global alerts related to recalls and falsified medicines identified through medical surveillance.
Global Challenge of Substandard and Counterfeit Medicines
The Background:
Health authorities worldwide and concerned agencies such as World Health Organization, regularly publish alerts related to medicinal products violating the quality standards. This includes statutory or voluntary recalls and alerts related to substandard, counterfeit or falsified medicines. The recalls and alerts are classified by different health agencies based on the impact of such violations on patient safety.
- Class 1: Medicines posing the highest risk, with potential to cause serious harm or even death.
- Class 2: Products that may lead to temporary or reversible health problems.
- Class 3: Cases where the medicine is unlikely to cause any harmful reaction.
In addition, regular notifications on falsified medicines are published by the health agencies.
The challenge:
There was no centralized and harmonized standard for tracking such alerts by regulatory, procurement, custom officials and other government agencies. Often data is published in different platforms, templates and formats. The data is scattered presenting challenge in identifying products or manufacturers that need to be considered.
Our client required a solution to address these gaps, by leveraging Artificial Intelligence, Natural Language Processing and Machine Learning. The client required a system that could require minimum or no data governance, thus, reduced maintenance cost of the system.
We have explored the role of artificial intelligence in medical device regulatory affairs in another article.
To overcome these challenges, the client needed an intelligent, scalable, and cost-effective solution — and that’s where Artixio stepped in.
Artixio’s AI-Powered Solution
Artixio developed an innovative, first of its kind, risk scoring system leveraging different parameters to rank manufacturers based on number and severity of violations. Leveraging in-house team of regulatory, data science, artificial intelligence engineers, Artixio deployed a technology solution integrating the data scraping, data pipelines, structuring and built in decision matrix to populated easy to refer dashboards for different stakeholders.
The system was conceptualized and built in short span of time delivering significant value through innovation based on Artixio’s regulatory experience and excellence in engineering. Client benefited from significant time and cost saving as a result of rapid, agile development strategies deployed by Artixio.
Artixio offers artificial intelligence, machine learning engineering solutions for the life sciences industry. We differentiate with our deep understanding of the life sciences industry across pharmaceuticals, medical devices, diagnostics, healthcare and other areas coupled with decades of proven experience in launching cutting edge technology solutions.
If you would like to discuss your requirement, ideas for AI/ML based solutions development, we would love to hear from you.
Request Assistance For
